Coronary/Structural Heart

Able Medical Announces First Surgeries and Launch of the Valkyrie™ Thoracic Fixation System

A novel single-use, bioactive sternal plating system for use after open heart surgery. MARQUETTE, Mich.–(BUSINESS WIRE)–Able Medical Devices announces the recent launch of its Valkyrie™ Thoracic Fixation System, the market’s first single-use radiolucent plating system designed to span the osteotomy and close the sternum after open heart surgery. The system’s […]

Predictive Health Diagnostics Company Announces Strong Momentum with 120,000th PULS Cardiac Test™ Order

One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care IRVINE, Calif., June 9, 2021 /PRNewswire/ — Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), a diagnostics development platform company that develops, manufactures, and distributes specialty diagnostic tests combining science, technology, and proprietary analytics to detect diseases with significant unmet medical needs, today announced […]

Heart & Vascular Center at Valley View Offers Open Heart Surgery and New Cardiothoracic Procedures, Under the Leadership of Cardiothoracic Surgeon Stephen Jones, MD

New Procedures Include Open Heart Surgery, Minimally Invasive Surgical Approaches for Atrial Fibrillation and Heart Valves, and Lung Cancer Operations GLENWOOD SPRINGS, Colo., June 9, 2021 /PRNewswire/ — The Heart & Vascular Center at Valley View is pleased to introduce new services to continue to provide patients with world-class, convenient and compassionate care on […]

Results From Sequana Medical’s RED DESERT alfapump DSR® Study Selected for Presentation at the Heart Failure 2021 Online Congress

GHENT, Belgium, June 09, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that the abstract on the results from its RED DESERT alfapump DSR (Direct Sodium […]

Sensible Medical and Heart Beat Medical Sign Partnership to Provide UAE with ReDS, Heart Failure Management Solution

ReDS Pulmonary Congestion Monitoring Technology will be Showcased at Upcoming Arab Health Exhibition NETANYA, Israel, June 8, 2021 /PRNewswire/ — Sensible Medical Innovations, the market leader in medical radar monitoring and imaging technology (ReDS™) has signed a partnership with Heart Beat Medical, Dubai, UAE – a leading medical device distributor. This agreement will enable […]

Baxter Presents Data at 58th ERA-EDTA Congress Indicating Theranova May Reduce Cardiovascular Events and Hospitalizations

Large, multicenter, retrospective study of Colombian dialysis patients indicates cardiovascular events were 35% lower for patients on HDx therapy enabled by Theranova than participants on standard hemodialysis1 Data from study also show HDx therapy may reduce hospitalization rates up to 18%1 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced […]

Heart-Valve-Surgery.com Launches “Clinical Trials Education Platform” to Educate & Empower Heart Valve Patients

TORRANCE, Calif., June 4, 2021 /PRNewswire/ — Heart-Valve-Surgery.com, a leading patient advocacy group for patients with heart valve disease, today launched the first phase of an end-to-end digital platform for patient awareness, patient education and patient enrollment specific to clinical trials. The new platform – which leverages novel algorithms and technologies – was […]

Peijia Medical and CR PHARMA COMM Sign Memorandum of Strategic Cooperation

SUZHOU, China, June 4, 2021 /PRNewswire/ — Peijia Medical Limited signed a memorandum of strategic cooperation with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. on June 2. Going forward, the two parties will collaborate intensively on the commercialization of TAVR products, ultimately providing more Chinese medical staff and patients with better quality […]

Abbott Confirms Capacity to Support Expanded Use of HeartMate 3™ Heart Pump

– Abbott has the capacity and supply to support increased demand for mechanical circulatory support (MCS) devices following Medtronic’s decision to stop the global distribution and sale of the Medtronic HeartWare™ ventricular assist device (HVAD) – Access to MCS devices are critical for advanced heart failure patients and can improve […]

Medtronic to Stop Distribution and Sale of HVAD™ System

– Company Developing Support Program for Current HVAD Patients – Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, is stopping the distribution and sale of the Medtronic HVAD™ System. This morning, the […]